MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Diplomat Pharmacy Company Profile (NASDAQ:DPLO)

Consensus Ratings for Diplomat Pharmacy (NASDAQ:DPLO) (?)
Ratings Breakdown: 6 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $36.50 (19.09% upside)

Analysts' Ratings History for Diplomat Pharmacy (NASDAQ:DPLO)
Show:
DateFirmActionRatingPrice TargetActions
5/18/2016Credit SuisseReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2016MizuhoBoost Price TargetNeutral$30.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Wells FargoReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Leerink SwannReiterated RatingBuy$35.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/18/2016Avondale PartnersInitiated CoverageOutperform$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016JPMorgan Chase & Co.DowngradeOverweight -> Neutral$52.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2016BarclaysInitiated CoverageOverweight -> Overweight$41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Raymond JamesLower Price TargetOutperform$55.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2015Bank of AmericaUpgradeUnderperform -> Neutral$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2015Morgan StanleyDowngradeOverweight -> Equal Weight$58.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015Robert W. BairdBoost Price TargetOutperform$40.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/24/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha